D. G. R. McLeod - Concepedia

Author

D. G. R. McLeod

Also Known As

D G McLeod, D G Mcleod, D McLeod, D. G. McLEOD, D. G. McLeod, D. G. R. MCLEOD, D. G. R. McLEOD, D. G. R. McLeod, D. Glenn R. McLeod, D. McLeod

Publications

Citations

H-Index

107

Concepts

All Affiliations

Walter Reed Army Institute of Research Uniformed Services University of the Health Sciences Armed Forces Institute of Pathology Walter Reed National Military Medical Center Agriculture and Agri-Food Canada

About

D. G. R. McLeod is an author at Walter Reed Army Institute of Research specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	24	1.8K
2	Natural Sciences	7	7	140
3	Engineering	4	4	88
4	Health Sciences	2	2	112
5	Business	1	1	15

D. G. R. McLeod

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Jaya P. Gaddipati, D. G. R. McLeod, Howard B. Heidenberg, PubMed Androgen ReceptorUrologyFrequent DetectionCodon 877Medicine	1994	364
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation Chen Sun, Albert Dobi, Ahmed A. Mohamed, Oncogene Common Genomic AlterationMedicineCancer GenomicsCell BiologyTumor Suppressor	2008	247
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification Bungo Furusato, Shyh‐Han Tan, Denise Young, Prostate Cancer and Prostatic Diseases	2010	238
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence Dorota J. Hawksworth, Lakshmi Ravindranath, Y Chen, Prostate Cancer and Prostatic Diseases Oncogenic AgentMedicinePathologyCancer GenomicsCancer Biology	2010	160
Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. Marie‐Claude Bettencourt, John J. Bauer, Isabell A. Sesterhenn, PubMed	1996	150
Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer Mark S. Soloway, ROOHOLIAH SHARIFI, Zev Wajsman, The Journal of Urology	1995	148
A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group Raymond S. Lance, P.A. Freidrichs, Christopher J. Kane, British Journal of Urology	2001	121
p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy. John J. Bauer, Isabell A. Sesterhenn, Kash Mostofi, PubMed UrologyPerineural InvasionDisease ProgressionGenitourinary CancerIndependent Prognostic Marker	1995	104
PHOTOPERIODIC TERMINATION OF DIAPAUSE IN AN INSECT D. G. R. McLeod, Stanley D. Beck Biological Bulletin BiologyEuropean Corn BorerDevelopmental BiologyDiapause DevelopmentInsect Conservation	1963	92
Comparison of Estramustine Phosphate, Methotrexate and cis-Platinum: in Patients with Advanced1 Hormone Refractory Prostate Cancer S.A. Loening, S. Beckle, Mark F. Brady, The Journal of Urology UrologyGenitourinary CancerMedicinePharmacologyClinical Trials	1983	86

Page 1